A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects
Clinical trial NCT07484893 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07484893
- Sponsor
- Shanghai Henlius Biotech
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-14
- Primary completion
- 2026-08-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.